S&P 500   3,852.36
DOW   32,920.46
QQQ   300.92
15 Ways to Improve Your Credit
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
These 2 Healthcare Stocks Have Doubled in 2023
Bed Bath & Beyond Is Circling the Drain
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Pfizer Stock: What the Bulls and Bears are Getting Wrong
Allegro Microsystems Is A Well-Positioned Semiconductor Stock
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
AMD Results Are No Reason To Buy Semiconductors... Yet
Institutions are Buying up Procter & Gamble Shares, Should you?
S&P 500   3,852.36
DOW   32,920.46
QQQ   300.92
15 Ways to Improve Your Credit
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
These 2 Healthcare Stocks Have Doubled in 2023
Bed Bath & Beyond Is Circling the Drain
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Pfizer Stock: What the Bulls and Bears are Getting Wrong
Allegro Microsystems Is A Well-Positioned Semiconductor Stock
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
AMD Results Are No Reason To Buy Semiconductors... Yet
Institutions are Buying up Procter & Gamble Shares, Should you?
S&P 500   3,852.36
DOW   32,920.46
QQQ   300.92
15 Ways to Improve Your Credit
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
These 2 Healthcare Stocks Have Doubled in 2023
Bed Bath & Beyond Is Circling the Drain
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Pfizer Stock: What the Bulls and Bears are Getting Wrong
Allegro Microsystems Is A Well-Positioned Semiconductor Stock
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
AMD Results Are No Reason To Buy Semiconductors... Yet
Institutions are Buying up Procter & Gamble Shares, Should you?
S&P 500   3,852.36
DOW   32,920.46
QQQ   300.92
15 Ways to Improve Your Credit
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
These 2 Healthcare Stocks Have Doubled in 2023
Bed Bath & Beyond Is Circling the Drain
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Pfizer Stock: What the Bulls and Bears are Getting Wrong
Allegro Microsystems Is A Well-Positioned Semiconductor Stock
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
AMD Results Are No Reason To Buy Semiconductors... Yet
Institutions are Buying up Procter & Gamble Shares, Should you?
NASDAQ:SYNH

Syneos Health - SYNH Price Target & Analyst Ratings

$37.76
+1.84 (+5.12%)
(As of 02/1/2023 12:00 AM ET)
Add
Compare
Today's Range
$35.73
$37.86
50-Day Range
$33.59
$37.76
52-Week Range
$22.89
$92.62
Volume
1.31 million shs
Average Volume
1.67 million shs
Market Capitalization
$3.89 billion
P/E Ratio
13.73
Dividend Yield
N/A
Price Target
$53.60

Syneos Health Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Hold
Based on 10 Analyst Ratings

Consensus Analyst Price Target

$53.60
41.95% Upside
High Prediction$81.00
Average Prediction$53.60
Low Prediction$25.00
TypeCurrent
2/2/22 to 2/2/23
1 Month Ago
1/3/22 to 1/3/23
3 Months Ago
11/4/21 to 11/4/22
1 Year Ago
2/2/21 to 2/2/22
Consensus Rating
Hold
Hold
Hold
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
2 Buy rating(s)
3 Buy rating(s)
5 Buy rating(s)
5 Buy rating(s)
Hold
7 Hold rating(s)
7 Hold rating(s)
6 Hold rating(s)
1 Hold rating(s)
Sell
1 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$53.60$54.10$72.09$104.50
Predicted Upside41.95% Upside20.16% Upside19.56% Upside12.92% Upside
Get Syneos Health Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for SYNH and its competitors with MarketBeat's FREE daily newsletter.


SYNH Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

SYNH Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Syneos Health Stock vs. The Competition

TypeSyneos HealthMedical CompaniesS&P 500
Consensus Rating Score
2.10
2.65
2.46
Consensus RatingHoldBuyHold
Predicted Upside41.95% Upside1,301.26% Upside8.14% Upside
News Sentiment RatingNeutral News
Positive News
Neutral News

Historical Target Prices and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
1/13/2023Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOverweight ➝ Underweight$30.00 ➝ $25.00-27.47%
12/14/2022Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Neutral$66.00 ➝ $38.00+7.04%
11/9/2022Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$77.00 ➝ $51.00+71.60%
11/7/2022Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform$80.00 ➝ $42.00+63.42%
11/6/2022Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetNeutral$55.00 ➝ $30.00+16.73%
10/18/2022JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOverweight ➝ Neutral$85.00 ➝ $53.00+9.98%
9/14/2022Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Neutral
9/7/2022UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageNeutral$68.00+14.27%
8/9/2022Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$73.00+7.99%
8/3/2022William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOutperform ➝ Market Perform
4/25/2022Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold$101.00 ➝ $75.00-2.80%
11/4/2021KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight$100.00 ➝ $105.00+5.08%
8/5/2021Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform$96.00 ➝ $100.00+14.63%
12/9/2020Smith Barney Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$75.00 ➝ $80.00+21.07%
10/1/2020The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeNeutral ➝ Buy$69.00 ➝ $75.00+41.08%
8/12/2020Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy$74.00 ➝ $80.00+27.98%
7/16/2020SunTrust Banks
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy$66.00 ➝ $74.00+20.36%
4/30/2020Cfra
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy$55.00 ➝ $61.00+8.72%
(Data available from 2/2/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)












SYNH Price Target - Frequently Asked Questions

What is Syneos Health's consensus rating and price target?

According to the issued ratings of 10 analysts in the last year, the consensus rating for Syneos Health stock is Hold based on the current 1 sell rating, 7 hold ratings and 2 buy ratings for SYNH. The average twelve-month price prediction for Syneos Health is $53.60 with a high price target of $81.00 and a low price target of $25.00. Learn more on SYNH's analyst rating history.

Do Wall Street analysts like Syneos Health more than its competitors?

Analysts like Syneos Health less than other Medical companies. The consensus rating for Syneos Health is Hold while the average consensus rating for medical companies is Buy. Learn more on how SYNH compares to other companies.

Is Syneos Health being downgraded by Wall Street analysts?

Over the previous 90 days, Syneos Health's stock had 2 downgrades by analysts.

Does Syneos Health's stock price have much upside?

According to analysts, Syneos Health's stock has a predicted upside of 16.53% based on their 12-month price targets.

What analysts cover Syneos Health?

Syneos Health has been rated by Barclays, Citigroup, Deutsche Bank Aktiengesellschaft, Mizuho, and Robert W. Baird in the past 90 days.


Stock Ratings Reports and Tools

This page (NASDAQ:SYNH) was last updated on 2/2/2023 by MarketBeat.com Staff